
Cognito Therapeutics Unveils Breakthrough in Alzheimer’s Care with Non-Invasive Neuromodulation Therapy
New Clinical Data Shows Significant Delay in Disease Progression and Cognitive Decline in Alzheimer’s Patients Using Cognito’s Wearable Neurotech

New Clinical Data Shows Significant Delay in Disease Progression and Cognitive Decline in Alzheimer’s Patients Using Cognito’s Wearable Neurotech

Researchers from the Keck School of Medicine of USC have developed a blood test that can identify early signs of Alzheimer’s disease by measuring proteins linked to the condition. The new test, known as Penta-Plex Alzheimer’s Disease Capture Sandwich Immunoassay (5ADCSI), detects five biomarkers simultaneously, which is more than existing blood tests and runs on equipment commonly used in many laboratories.

Go-Pen ApS announced recently that it received FDA 510(k) clearance for its Go-Pen cost-effective, user-filled insulin pen.

A subsidiary of Tandem Diabetes Care (Nasdaq:TNDM) recently picked up FDA clearance for infusion technology to support insulin delivery

The research team, led by Professor Minee L. Choi from the Department of Brain and Cognitive Sciences, in collaboration with University College London (UCL) and the Francis Crick Institute, discovered that the RNA-editing enzyme ADAR1 plays an important role in controlling immune responses in astrocytes, glial cells that trigger protective reactions in the brain, and demonstrated that this mechanism is critically involved in the progression of Parkinson’s disease.

Novocure (Baar, Switzerland) announced today that it has won a CE mark for its Optune Lua wearable device for treating metastatic non-small cell lung cancer.

ICU Medical (Nasdaq: ICUI) announced today that it received FDA 510(k) clearance for several new additions to its infusion pump portfolio.

U-Pump announced on social media that it reached a new milestone in its development of an AI-powered, reusable insulin patch pump.

SiBionics announced today that it unveiled its GS3 continuous glucose monitor (CGM), which now has CE mark approval.

Blood glucose is usually measured using invasive methods involving pricking small needles into the skin. But people suffering from diabetes have to test their glucose levels many times a day. This repeated use of needles is inconvenient and can increase the risk of potential infections.